ADPT Decodes Immune Responses, BBIO Develops Rare Disease Breakthroughs


Adaptive Biotechnologies Corporation (ADPT)

Adaptive Biotechnologies decodes the immune system using next-gen sequencing to develop diagnostics and immune-driven therapeutics. Chart.

BridgeBio Pharma, Inc. (BBIO)

BridgeBio Pharma focuses on genetic disease treatments, advancing a deep pipeline of targeted therapies for rare and underserved conditions. Chart.


 



 
Trending Ideas

Featured Stocks On The Move